Physician

Ophthalmology

Dr. Charles D. Brodrick, MD


Doctor Charles D. Brodrick, MD works in the field of Ophthalmology. He attended University of Texas Southwestern Medical School. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Charles D. Brodrick is also published. He has 1 publication published. The lastest publication: "Anhydrous ammonia eye injuries associated with illicit methamphetamine production.' He accepts all Medicare patients.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1336131499
NPPES Provider LastName   BRODRICK
NPPES Provider FirstName   CHARLES
NPPES Provider ZIPCode   782151918
NPPES Provider State   TX
Specialty Description   Ophthalmology
Total Claim Count   604.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1336131499
Last Name Of The Provider BRODRICK
First Name Of The Provider CHARLES
View All

Similar Doctors


Dr. Timithy M. Dunham, MD
This Doctor is OpenDoctor Recommended.
Dr. David G. Shulman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Barbara L. Ku, MD
This Doctor is OpenDoctor Recommended.
Dr. Harrison N. Bowes Jr., MD
This Doctor is OpenDoctor Recommended.
Dr. Steven Chalfin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Antonio A. San Martin, MD
This Doctor is OpenDoctor Recommended.
Dr. Joseph B. Frey, MD
This Doctor is OpenDoctor Recommended.
Dr. Malvin C. Driver Jr., MD
This Doctor is OpenDoctor Recommended.
Dr. Douglas J. Ivan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. James M. Eggers, MD
Dr. Chad H. Jackson, MD
Dr. Steven R. Grimes, MD
Dr. Daniel R. Lamothe, MD
This Doctor is OpenDoctor Recommended.
Dr. Kenneth H. Zaslow, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog